Skip to main content

Edgestream Partners, L.P.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1535061 Princeton, NJ

Position in NBIX

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$6,664,331
+$3,599,669 QoQ
Shares Held
50,587
+134.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $28,592,165 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (23.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
50,587 $6,664,331

All Filings in NBIX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,664,331 50,587
2025-12-31 $3,064,662 21,608
2025-09-30 $555,764 3,959
2025-06-30 $9,251,286 73,604
2024-12-31 $1,716,351 12,574
2024-09-30 $606,748 5,266
2024-06-30 $6,084,187 44,194
2024-03-31 $3,310,769 24,005
2023-12-31 $1,845,035 14,003
2023-09-30 $230,175 2,046
2023-06-30 $1,197,892 12,703
2023-03-31 $3,772,671 37,272
2022-12-31 $2,168,313 18,154
2022-09-30 $933,479 8,789
2022-06-30 $503,874 5,169
2022-03-31 $2,449,031 26,123
2021-12-31 $3,922,589 46,056
2021-03-31 $861,343 8,857